These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16344676)
21. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. Dunphy CH; Kitchen S; Saravia O; Velasquez WS Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944 [TBL] [Abstract][Full Text] [Related]
22. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S; Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289 [TBL] [Abstract][Full Text] [Related]
23. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518 [TBL] [Abstract][Full Text] [Related]
24. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874 [TBL] [Abstract][Full Text] [Related]
25. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes. Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462 [TBL] [Abstract][Full Text] [Related]
26. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India. Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917 [TBL] [Abstract][Full Text] [Related]
27. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Soslow RA; Davis RE; Warnke RA; Cleary ML; Kamel OW Blood; 1996 Jun; 87(12):5207-12. PubMed ID: 8652834 [TBL] [Abstract][Full Text] [Related]
28. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia]. Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858 [TBL] [Abstract][Full Text] [Related]
29. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study. Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908 [TBL] [Abstract][Full Text] [Related]
30. High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Reismüller B; Steiner M; Pichler H; Dworzak M; Urban C; Meister B; Schmitt K; Pötschger U; König M; Mann G; Haas OA; Attarbaschi A; Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27804199 [TBL] [Abstract][Full Text] [Related]
31. Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. Hunault-Berger M; Milpied N; Bernard M; Jouet JP; Delain M; Desablens B; Sadoun A; Guilhot F; Casassus P; Ifrah N Leukemia; 2001 Jun; 15(6):898-902. PubMed ID: 11417474 [TBL] [Abstract][Full Text] [Related]
32. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect. Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027 [TBL] [Abstract][Full Text] [Related]
33. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Lauten M; Cario G; Asgedom G; Welte K; Schrappe M Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754 [TBL] [Abstract][Full Text] [Related]
34. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
36. Benign intracranial hypertension in association with acute lymphoblastic leukemia. Sastry J; Karandikar SS; English MW Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527 [No Abstract] [Full Text] [Related]
37. Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia. Buendia MT; Terselich G; Lozano JM; Viscaino MP Med Pediatr Oncol; 1997 Feb; 28(2):108-16. PubMed ID: 8986146 [TBL] [Abstract][Full Text] [Related]
38. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
39. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia. Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009 [TBL] [Abstract][Full Text] [Related]